Biofrontera Inc. (BFRI) reported Q3 EPS of ($0.11), $0.18 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $4.31 million.
Biofrontera Inc. (BFRI) reported Q3 EPS of ($0.11), $0.18 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $4.31 million.